Last updated on August 2018

A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of investigational doses of dulaglutide in participants with type 2 diabetes on metformin monotherapy.

Clinical Study Identifier: NCT02973100

Contact Investigators or Research Sites near you

Start Over

Leslie Klaff

Rainier Clinical Research Center
Renton, WA United States